{"id":"https://openalex.org/W7204167045","doi":"https://doi.org/10.33320/maced.pharm.bull.2026.72.03.149","title":"Effect of stationary phase selection on the chromatographic behavior of formoterol fumarate and fluticasone propionate","display_name":"Effect of stationary phase selection on the chromatographic behavior of formoterol fumarate and fluticasone propionate","publication_year":2026,"publication_date":"2026-10-01","ids":{"openalex":"https://openalex.org/W7204167045","doi":"https://doi.org/10.33320/maced.pharm.bull.2026.72.03.149"},"language":"en","primary_location":{"id":"pmh:oai:doaj.org/article:630c787d5e59488aac7e494bb50ead3b","doi":"https://doi.org/10.33320/maced.pharm.bull.2026.72.03.149","is_oa":false,"landing_page_url":"https://doaj.org/article/630c787d5e59488aac7e494bb50ead3b","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Makedonsko Farmacevtski Bilten, Vol 72, Iss 3, Pp 309-310 (2026)","raw_type":"article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["doaj"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043861981","display_name":"Gabriela Petrovska-Dimitrievska","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gabriela Petrovska-Dimitrievska","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148091962","display_name":"Sanja Serafimova","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sanja Serafimova","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015898693","display_name":"Biljana Atanasovska","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Biljana Atanasovska","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003593026","display_name":"Liljana Ugrinova","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Liljana Ugrinova","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050468643","display_name":"Hrisanta Godzo","orcid":"https://orcid.org/0000-0002-6805-0587","observed_orcids":["https://orcid.org/0000-0002-6805-0587"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hrisanta Godzo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5050307435","display_name":"Marija Zafirova Gjorgievska","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marija Zafirova Gjorgievska","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.5,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.5,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10908","display_name":"Analytical Chemistry and Chromatography","score":0.4821999967098236,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/stationary-phase-selection","display_name":"stationary phase selection","score":0.8500000238418579},{"id":"https://openalex.org/keywords/formoterol-fumarate","display_name":"formoterol fumarate","score":0.9509999752044678},{"id":"https://openalex.org/keywords/fluticasone-propionate","display_name":"fluticasone propionate","score":1.0},{"id":"https://openalex.org/keywords/inhaled-corticosteroids","display_name":"inhaled corticosteroids","score":0.7689999938011169},{"id":"https://openalex.org/keywords/beta-2-adrenergic-agonists","display_name":"beta2-adrenergic agonists","score":0.7760000228881836},{"id":"https://openalex.org/keywords/gas-chromatography","display_name":"gas chromatography","score":0.49799999594688416},{"id":"https://openalex.org/keywords/chromatographic-behavior","display_name":"chromatographic behavior","score":0.6650000214576721}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8123000264167786},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.7215999960899353},{"id":"https://openalex.org/C2909086917","wikidata":"https://www.wikidata.org/wiki/Q637247","display_name":"Formoterol Fumarate","level":5,"score":0.6883999705314636},{"id":"https://openalex.org/C2779871671","wikidata":"https://www.wikidata.org/wiki/Q637247","display_name":"Formoterol","level":4,"score":0.6391000151634216},{"id":"https://openalex.org/C2983406500","wikidata":"https://www.wikidata.org/wiki/Q7604347","display_name":"Stationary phase","level":2,"score":0.5182999968528748},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.49399998784065247},{"id":"https://openalex.org/C2779028295","wikidata":"https://www.wikidata.org/wiki/Q8564098","display_name":"Fluticasone propionate","level":3,"score":0.4230000078678131},{"id":"https://openalex.org/C2780014933","wikidata":"https://www.wikidata.org/wiki/Q422956","display_name":"Propionate","level":2,"score":0.41679999232292175},{"id":"https://openalex.org/C81917197","wikidata":"https://www.wikidata.org/wiki/Q628760","display_name":"Selection (genetic algorithm)","level":2,"score":0.37950000166893005},{"id":"https://openalex.org/C2776819417","wikidata":"https://www.wikidata.org/wiki/Q418123","display_name":"Dimethyl fumarate","level":3,"score":0.336899995803833},{"id":"https://openalex.org/C2993377673","wikidata":"https://www.wikidata.org/wiki/Q5101828","display_name":"Chiral stationary phase","level":3,"score":0.32519999146461487},{"id":"https://openalex.org/C45188465","wikidata":"https://www.wikidata.org/wiki/Q645497","display_name":"Reversed-phase chromatography","level":3,"score":0.3061999976634979},{"id":"https://openalex.org/C2911225412","wikidata":"https://www.wikidata.org/wiki/Q422956","display_name":"Propionates","level":2,"score":0.3012999892234802}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:doaj.org/article:630c787d5e59488aac7e494bb50ead3b","doi":"https://doi.org/10.33320/maced.pharm.bull.2026.72.03.149","is_oa":false,"landing_page_url":"https://doaj.org/article/630c787d5e59488aac7e494bb50ead3b","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Makedonsko Farmacevtski Bilten, Vol 72, Iss 3, Pp 309-310 (2026)","raw_type":"article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2396531759","https://openalex.org/W4238039604","https://openalex.org/W2323855292","https://openalex.org/W1969872891","https://openalex.org/W2607685299","https://openalex.org/W2436304210","https://openalex.org/W2585401344","https://openalex.org/W2979508320","https://openalex.org/W2598336030","https://openalex.org/W614439349"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2026-08-26T00:00:00"}